1. Home
  2. QTTB vs TOMZ Comparison

QTTB vs TOMZ Comparison

Compare QTTB & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • TOMZ
  • Stock Information
  • Founded
  • QTTB 2015
  • TOMZ 1979
  • Country
  • QTTB United States
  • TOMZ United States
  • Employees
  • QTTB N/A
  • TOMZ N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • TOMZ Diversified Commercial Services
  • Sector
  • QTTB Health Care
  • TOMZ Finance
  • Exchange
  • QTTB Nasdaq
  • TOMZ Nasdaq
  • Market Cap
  • QTTB 23.3M
  • TOMZ 20.4M
  • IPO Year
  • QTTB N/A
  • TOMZ N/A
  • Fundamental
  • Price
  • QTTB $1.67
  • TOMZ $0.88
  • Analyst Decision
  • QTTB Hold
  • TOMZ Strong Buy
  • Analyst Count
  • QTTB 8
  • TOMZ 1
  • Target Price
  • QTTB $24.00
  • TOMZ $3.50
  • AVG Volume (30 Days)
  • QTTB 104.5K
  • TOMZ 34.4K
  • Earning Date
  • QTTB 08-06-2025
  • TOMZ 10-29-2025
  • Dividend Yield
  • QTTB N/A
  • TOMZ N/A
  • EPS Growth
  • QTTB N/A
  • TOMZ N/A
  • EPS
  • QTTB N/A
  • TOMZ N/A
  • Revenue
  • QTTB N/A
  • TOMZ $6,219,036.00
  • Revenue This Year
  • QTTB N/A
  • TOMZ $18.31
  • Revenue Next Year
  • QTTB N/A
  • TOMZ $103.30
  • P/E Ratio
  • QTTB N/A
  • TOMZ N/A
  • Revenue Growth
  • QTTB N/A
  • TOMZ N/A
  • 52 Week Low
  • QTTB $1.35
  • TOMZ $0.63
  • 52 Week High
  • QTTB $53.79
  • TOMZ $1.50
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 42.51
  • TOMZ 47.34
  • Support Level
  • QTTB $1.62
  • TOMZ $0.79
  • Resistance Level
  • QTTB $1.82
  • TOMZ $0.98
  • Average True Range (ATR)
  • QTTB 0.16
  • TOMZ 0.05
  • MACD
  • QTTB -0.02
  • TOMZ 0.01
  • Stochastic Oscillator
  • QTTB 10.42
  • TOMZ 52.86

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.

Share on Social Networks: